VALCHLOR: payments to doctors
Payments that named VALCHLOR as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3.7M
- Providers
- 3,275
- Transactions
- 7,035
- Average per transaction
- $525
The per-transaction average — $525 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,275 providers the average total is $1,127, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Helsinn Healthcare SA | $2,958,879 | 80.2% |
| Helsinn Therapeutics (U.S.), Inc. | $732,378 | 19.8% |
| Verity Pharmaceuticals Inc. | $69 | 0.0% |